Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study. 7. Juni 2015 Marschner, N., Arnold, D., Engel, E., Hutzschenreuter, U., Rauh, J., Freier, W., Hartmann, H., Frank, M., Jänicke, M., 2015. Clinical Epidemiology 7, 295–303. doi:10.2147/CLEP.S73857 Abstract NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim – First Interim Analysis. Kurbacher, C.M., Fietz, T., Diel, I.J., Egert, M., Hurtz, H.-J., Lück, A., Weide, R., Salat, C., Wolff, T., Zaiss, M., Klare, P., Losem, C., Illmer,… Weiterlesen Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry. Marschner, N., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Goebell, P., 2015. Oncol Res Treat 38 (suppl.5)(V674), 204. doi:10.1159/000439070… Weiterlesen